If you have irregular cycles, severe dysmenorrhea, or hormonal imbalances, your provider should monitor GLP-1 tolerability more closely during your period
You can read more about the cookies that we use and their purposes and update your settings at any time.
And its a problem that you need to fix, before any more life passes you by
In terms of efficacy, the early study showed that patients treated with subcutaneous AZD6234 experienced a statistically significant decrease in body weight compared with placebo
Semaglutide for managing overweight and obesity consultation document (GID-TA10765)
By July 2026, that share had soared to 11 percent, with 15 percent saying they had at some point tried a GLP-1 drug such as Ozempic or Wegovy for weight loss